美高梅·游戏(MGM)官方网站-Platform entrance

Tianjin Dexiang Biotechnology Co., Ltd.(hereinafter referred to as " Dexbio") was established on December16, 2011. Located in the Binhai New Area, the first national comprehensive reform and innovation zone approved by the State Council, it is a key investment project in Tianjin Economic-Technological Development Area (TEDA).With a registered capital of 30 million RMB and a total project investment exceeding 100 million RMB, Dexbio is a high-tech enterprise integrating research and development, production, and sales in the field of in vitro diagnostics.